Lithuanian isolates of Escherichia coli and Salmonella enterica from animals and humans were examined for resistance to quinolones, fluoroquinolones and for resistance-associated mutations. 9% of S. enterica from animals and 4% of isolates from clinical samples of humans were resistant to nalidixic acid and susceptible to fluoroquinolones. DNA analysis of nalidixic acid-resistant S.enterica strains from animals revealed a single mutation at codon 83 (Ser→Phe) in gyrA gene, whereas resistant clinical strains contained a single gyrA mutation at codon 87 (Asp→Tyr). 10% of human isolates of E. coli were resistant to nalidixic acid and ciprofloxacin. 22% of E. coli isolates from calves were resistant to nalidixic acid. 40% and 20% of E. coli isolates from pigs were resistant to nalidixic acid and to fluoroquinolones, respectively. E. coli isolates of animal and human origin analyzed for nalidixic acid resistance-associated mutations carried single mutations at codon 83 (Ser→Leu) or at codon 87 (Asp→Tyr) in gyrA gene. Fluoroquinolone-resistant E. coli isolates from calves and humans carried multiple mutations within gyrA (83Ser→Leu, 87Asp→Gly or Asn) and parC (80Ser→Ile or Arg, 84Glu→Val or Lys) genes.

Issues:

2011 - Vol.57
No. 1, No. 2, No. 3

2010 - Vol.56
No. 1-4

2009 - Vol.55
No. 1-2, No. 3-4

2008 - Vol.54
No. 1, No. 2, No. 3, No. 4

2007 - Vol.53
No. 1, No. 2, No. 3, No. 4

2006
No. 1, No. 2, No. 3, No. 4

2005
No. 1, No. 2, No. 3, No. 4

2004
No. 1, No. 2, No. 3, No. 4

2003
No. 1, No. 2, No. 3, No. 4

2002
No. 1, No. 2, No. 3, No. 4

2001
No. 1, No. 2, No. 3, No. 4